n
|
Diagnosis
|
Age (years) @ start of HD
|
At time of first rtPA infusion
|
No of rtPA
|
Outcomes (as of 31 Dec 2012)
|
Age (years)
|
Duration of HD (years)
|
HD Sessions
|
0.1 mg/kg/h over 1 hour
|
0.1 mg/kg/h over 2 hours
|
0.2 mg/kg/h over 1 hour
|
0.2 mg/kg/h over 2 hours
|
1
|
Renal Dysplasia
|
2.4
|
4.9
|
2.5
|
390
|
3
|
4
|
2
|
0
|
Line remained in-situ x 2.5 years
|
2
|
Bilateral Wilm’s Tumour
|
2.0
|
3.1
|
1.1
|
171
|
6
|
4
|
30
|
5
|
Line remained in-situ x 2 years until transplant
|
3
|
Nephrotic syndrome
|
10.5
|
10.8
|
0.3
|
47
|
108
|
0
|
0
|
1
|
Line remained in-situ x 3.2 years
|
4
|
Posterior Urethral Valves
|
5.6
|
6.3
|
0.7
|
109
|
1
|
0
|
0
|
0
|
Line remained in-situ x 2.1 years until transplant
|
5
|
Renal Dysplasia
|
14.8
|
14.9
|
0.1
|
15
|
115
|
0
|
0
|
0
|
Line remained in-situ x 2.8 years
|
6
|
Primary Hyperoxalosis
|
0.3
|
1.7
|
1.4
|
218
|
10
|
0
|
22
|
1
|
Line remained in-situ x 1.2 years
|
7
|
Prune Belly Syndrome
|
8.5
|
9.6
|
1.1
|
172
|
2
|
0
|
0
|
0
|
Line remained in-situ x 0.75 years until transplant
|
8
|
Renal Dysplasia
|
0.5
|
0.9
|
0.4
|
62
|
1
|
2
|
10
|
1
|
Line remained in-situ x 0.2 years until transplant
|
9
|
Renal Dysplasia
|
13.9
|
14.5
|
0.6
|
94
|
2
|
0
|
0
|
0
|
Line remained in-situ x 0.3 years until transplant
|
10
|
Cystic Kidney Disease HNF1B
|
4.3
|
4.7
|
0.4
|
63
|
4
|
1
|
4
|
0
|
Line remained in-situ x 1 year until transplant
|